课题基金 / 基金详情

INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY

INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
阴道内产品对阴道生理的影响
批准号:
2206614
负责人:
David Eschenbach
金额:
$38.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-05-01 至 2000-04-30

项目摘要

项目成果

David Eschenbach的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The vagina is the staging site for many genital infections. The long-term goal of this project is to understand how use of vaginal products could increase or decrease susceptibility to infections acquired during sexual intercourse. Vaginal resistance to the development of infection is largely dependent upon three components: normal vaginal flora which inhibits microorganisms by producing a low pH and hydrogen peroxide, reducing the attachment of bacteria to the vaginal epithelium which reduces the ability of the bacteria to establish colonization, and an intact vaginal epithelium which mechanically resists invasion. Many prescribed and over- the-counter products placed in the vagina are known to potentially effect one or more of these vaginal protective mechanisms. This proposal is designed to examine the effects of a variety of conditions and products on the vaginal physiology. The effects under study include vaginal discharge, vaginal microbial flora, attachment of bacteria to vaginal epithelium and the cytology and histology of the vaginal epithelium. Quantitative vaginal cultures will be performed for selected species, attachment of Lactobacillus and Escherichia coli to the subject's vaginal epithelial cells will be examined and colposcopic, cytologic and histologic examination of the vaginal cell epithelium will be studied at baseline and under experimental conditions. We intend to examine the following conditions for their effect on the vaginal physiology: the normal menstrual cycle in the proliferative, luteal and menstrual phase, hormonal contraception, sexual intercourse with and without condoms, a variety of doses and frequent use of intravaginal spermicide containing nonoxynol-9, commonly used vaginal douche products, including one that contains povidone-iodine, the intravaginal instillation of hydrogen peroxide producing Lactobacillus, and menopause before and after estrogen replacement therapy. The research is intended to answer some of the questions of whether bacterial attachment varies during the menstrual cycle, under which conditions bacteria introduced into the vagina during intercourse contributes to the overgrowth of lactobacilli, the effect of hormonal contraception on bacterial growth, bacterial cell attachment and the epithelium, whether nonoxynol-9 or povidone-iodine use disturbs bacterial flora and causes vaginal epithelial damage, and if so, the extent of the damage, conditions where intravaginal Lactobacillus instillation leads to vaginal colonization and the effect of menopause and estrogen replacement on vaginal flora and bacterial attachment. Use of female-controlled vaginal microbicides will be an important public health measure to decrease the heterosexual transmission of sexually transmitted diseases including human immunodeficiency virus. The proposed studies will provide critical new information on endogenous and exogenous factors which effect vaginal physiology, and thereby alter resistance of the vagina to infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    8321592
  • 项目类别:
  • 资助金额:
    $47.34万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    6892116
  • 项目类别:
  • 资助金额:
    $24.99万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    8135531
  • 项目类别:
  • 资助金额:
    $4.0万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    7797147
  • 项目类别:
  • 资助金额:
    $47.34万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
国内基金
海外基金
肠道菌群Lactobacillus来源的吲哚-3- 甲醛对绝经后骨量丢失的保护机制研究
瘤内细菌 Lactobacillus iners 通过 eIF4A2 乳酸化介导肿瘤相关巨噬细胞极 化诱导膀胱癌免疫化疗抵抗的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    吴志明
  • 依托单位:
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    邱敬诚
  • 依托单位:
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
  • 批准号:
    82305009
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王文波
  • 依托单位: